Systemic lupus erythematosus (SLE) is an autoimmune disease, characterized by production of different autoantibodies, complement activation, and immune complex deposition. An association between SLE and cancer has long been known. In patients with SLE, the incidence and risk of overall malignancy is increased for lung cancer, cervical cancer, liver cancer, and etc. Conversely, the incidences of prostate, breast and ovarial cancers are decreased in a number of studies of SLE patients.
There are many factors, which can contribute to the development of malignancies in SLE. In this review we present some more common solid tumors and their incidence in SLE patients as well as the factors that affect tumorigenesis in conditions of autoimmune disease.
Койнов К. Оптимизиране на цитотоксична терапия при метастатичен тройнонегативен карцином на гърда. Клинично поведение при карцином на гърдата. Текстове за продължаващо обучение. 2013;177-186.
Ahmed MM, Berney SM, Wolf RE, Hearth-Holmes M, Hayat S, Mubashir E. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. Am J Med Sci 2006;331:252-5.
Antonelli A, Mosca M, Fallahi P, Neri R, Ferrari SM, D'Ascanio A, et al. Thyroid cancer in systemic lupus erythematosus: a case-control study. J Clin Endocrinol Metabol 2010;95(1):314-318.
Azzato EM, Lee AJ, Teschendorff A, Ponder BA, Pharoah P, Caldas C et al. Common germ-line polymorphism of C1QA and breast cancer survival. Br J Cancer 2010;102(8):1294-9.
Beral V, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369(9574):1703-10.
Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis 2008;67(1):74-9.
Bernatsky S, Ramsey-Goldman R, Foulkes WD, Gordon C, Clarke AE. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: A meta-analysis. Br J Cancer 2011; 104: 1478-81.
Bernatsky S, Ramsey-Goldman R, Gordon C, Clarke A. Prostate cancer in systemic lupus erythematosus. Int J Cancer 2011;129(12):2966-9.
Bernatsky S, Easton DF, Dunning A, Michailidou K, Ramsey-Goldman R, Gordon C, Clarke AE, Foulkes W. Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues. Lupus 2012;21(8):896-9.
Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. Cancer risk in systemic lupus: an updated international multicentre cohort study. J Autoimmun 2013;42:130-5.
Bernatsky SR, Ramsey-Goldman R, Petri M, Urowitz MB, Fortin PR, Yelin, E. et al. Smoking is the most significant modifiable lung cancer risk factor in SLE. J Rheum 2018;45(3):393-6.
Bin J, Bernatsky S, Gordon C, Boivin JF, Ginzler E, Gladman D, et al. Lung cancer in systemic lupus erythematosus. Lung Cancer 2007;56(3):303-6.
BjörnÃ¥dal L, Löfström B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheum 2002;31(2):66-71.
Blumenfeld Z, Lorber M, Yoffe N, Scharf Y. Systemic lupus erythematosus: predisposition for uterine cervical dysplasia. Lupus 1994;3(1):59-61.
Cao L, Tong H, Xu G, Liu P, Meng H, Wang J, et al. Systemic lupus erythematous and malignancy risk: a meta-analysis. PLoS One 2015;10(4):e0122964.
Castro FA, Liu X, Försti A, Ji J, Sundquist J, Sundquist K et al. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clin Gastroenterol Hepatol 2014;12(6). 1038-45.
Cervera R, Tincani A. European Working Party on systemic lupus erythematosus and European Forum on Antiphospholipid Antibodies: two networks promoting European research on autoimmunity. Lupus 2009;18(10):863-68
Chang SH, Park JK, Lee EB. Cancer incidence and type of malignancy in rheumatologic diseases in Korea: head-to-head comparison. Arthritis Rheum 2012;64:S44-5.
Chen Y-J, Chang Y-T, Wang C-B, Wu C-Y. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Amer J Med 2010;123(12):1150.e1-6.
Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017 31(3):373-96.
Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001;10(6):394-400.
Cooper GS, Dooley MA, Treadwell EL, Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, caseecontrol study. Arthritis Rheumatol 2002;46(7):1830-9.
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al. Cancer incidence in five continents, Vol. IX In IARC Scientific Publications No. 160 2007Lyon: IARC.
Dey D, Kenu E, Isenberg DA. Cancer complicating systemic lupus erythematosus - a dichotomy emerging from a nested case-control study. Lupus 2013;22:919-27.
DÃaz-Chávez J, Fonseca-Sánches MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-RodrÃguez Y, DomÃnguez-Gómez G et al. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS One 2013;8(5):e64378.
Dreyer L, Faurschou M, Mogensen M, Jacobsen S. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum 2011;63(10):3032-7.
Dugue P-A, Lynge E, Rebolj M. Increased risk of high-grade squamous intraepithelial lesions in systemic lupus erythematosus: additional data from Denmark. Autoimmun Rev 2014;12(13):1241-52.
Dugué PA, Rebolj M, Hallas J, Garred P, Lynge E. Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study. Int J Cancer 2015;136(6):E711-9.
Ekblom-kullberg S, Kautiainen H, Alha P, Leirisalo-repo M, Julkunen H. Smoking and the risk of systemic lupus erythematosus. Clin Rheumatol 2013;32(8):1219-22.
Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based caseecontrol study. Br J Cancer 2009;100(5):817-21.
Goobie GC, Bernatsky S, MD, Ramsey-Goldman R, MD, Clarke AE. Malignancies in Systemic Lupus Erythematosus - a 2015 Update. Curr Opin Rheumatol 2015; 27(5): 454-60.
Grzegrzolka J, Kurnol K, Piotrow P, Pula B, Kobierzycki C, Piotrowska A et al. Hsp27 expression in invasive ductal breast carcinoma. Folia Histo Cytobio 2012;50(4):527-533.
Hansen JE, Chan G, Liu Y, Hegan DC, Dalal S, Dray E. Targeting cancer with a lupus autoantibody. Sci Transl Med 2012;4(157):157ra142.
Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Resp J 2012;40:1489-95.
Huang HB, Jiang SC, Han J, Cheng QS, Dong CB, Pan CM. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus. J Cancer Res Clin Oncol 2014;140(7):1067-73.
Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, et al. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol 2010;29:381-8.
Kim SC, Glynn RJ, Giovannucci E, Hernández-DÃaz S, Liu J, Feldman S, et al. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis 2015;74(7):1360-7.
La Vecchia C, Franceschi S, Decarli A, Gallus G, Tognoni G. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 1984;73(3):667-71.
Liang J-A, Sun L-M, Yeh J-J, Lin W-Y, Chang S-N, Sung H-C. Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int 2012;32(3):773-8.
Liu X, Ji J, Forsti A, Sundquist K, Sundquist J, Hemminki K. Autoimmune disease and subsequent urological cancer. J Urol 2013;189(6):2262-8.
Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1:6.
Mao S, Shen H, Zhang J. Systemic lupus erythematosus and malignancies risk. J Cancer Res Clin Oncol. 2016;142(1):253-62.
Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthrit Rheum 1997; 40:761-768.
Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine 1983;62(5):327.
Ni J, Qiu LJ, Hu LF, Cen H, Zhang M, Wen PF, et al. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: a meta-analysis. Lupus 2014;23:284-92.
Nived O, Bengtsson A, Jönsen A, Sturfelt G, Olsson H. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus 2001;10(7):500-4.
Noble PW, Bernatsky S, Clarke AE, Isenberg DA, Ramsey-Goldman R, Hansen JE. DNA-damaging autoantibodies and cancer: the lupus butterfly theory. Nat Rev Rheumatol 2016 Jul;12(7):429-34.
Nyberg G, Eriksson O, Westberg NG. Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum 1981;24(5):648-50.
Ognenovski VM, Marder W, Somers EC, Johnston CM, Farrehi JG, Selvaggi SM, et al. Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol 2004;31(9):1763-7.
Parikh-Patel A, White RH, Allen M, Cress R. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control 2008;19(8):887-94.
Peeters PH, Verbeek AL, Krol A, Matthyssen MM, de Waard F. Age at menarche and breast cancer risk in nulliparous women. Breast Cancer Res Treat 1995;33(1):55-61.
Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann RhFeum Dis 1992;51:437-9.
Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC et al. Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 1997;89(15):1110-6.
Radanova M, Vasilev V, Dimitrov T, Deliyska B, Ikonomov V, Ivanova D. Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients. Lupus 2015;24:280-9.
Ragnarsson O, Grâ‚ondal G, Steinsson K. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Lupus 2003;12(9):687-91.
Rahim R, Strobl JS. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Anticancer Drugs. 2009;20(8):736-45.
Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL, et al. Increased risk of malignancy in patients with systemic lupus erythematosus. J Investig Med 1998;46(5):217-22.
Rosenberger A, Sohns M, Friedrichs S, Hung RJ, Fehringer G, McLaughlin J et al. Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus. PLoS One 2017;12(3):e0173339.
Santana IU, Gomes Ado N, Lyrio LD, Rios Grassi MF, Santiago MB. Systemic lupus erythematosus, human papillomavirus infection, cervical premalignant and malignant lesions: a systematic review. Clin Rheumatol 2011;30(5):665-72.
Straume O, Shimamura T, Lampa MJ, Carretero J, Øyan AM, Jia D. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci USA 2012;109(22):8699-8704.
Tallbacka KR, Pettersson T, Pukkala E. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up. Scand J Rheumatol 2018;00:1-4.
Tam LS, Chan AY, Chan PK, Chang AR, Li EK. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 2004 Nov;50(11):3619-25.
Tessier Cloutier B, Clarke AE, Ramsey-Goldman R, Wang Y, Foulkes W, Gordon C. Breast cancer in systemic lupus erythematosus. Oncology 2013;85(2):117-21.
Wadström H, Arkema EV, Sjöwall C, Askling J, Simard JF. Cervical neoplasia in systemic lupus erythematosus: a nationwide study. Rheumatology (Oxford) 2017;56(4):613-9.
Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, et al. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 2004;328(7451):1285.
Zard E, Arnaud L, Mathian A, Chakhtoura Z, Hie M, Touraine P, et al. Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature. Autoimmun Rev 2014;13(7):730-5.
